To include your compound in the COVID-19 Resource Center, submit it here.

Doggett urging CMS transparency on Kymriah price

Rep. Lloyd Doggett (D-Texas) penned a letter to the Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma requesting transparency of the pricing agreement for Kymriah tisagenlecleucel from Novartis AG

Read the full 311 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE